en
Scientific article
English

Combination lipid-lowering therapy as first-line strategy in very high-risk patients

Published inEuropean heart journal, vol. 43, no. 8, p. 830-833
Publication date2022-02-22
Keywords
  • Anticholesteremic Agents* / therapeutic use
  • Cholesterol, LDL
  • Drug Therapy, Combination
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Hypolipidemic Agents / therapeutic use
Funding
  • Amgen and Sanofi -
Citation (ISO format)
RAY, Kausik K et al. Combination lipid-lowering therapy as first-line strategy in very high-risk patients. In: European heart journal, 2022, vol. 43, n° 8, p. 830–833. doi: 10.1093/eurheartj/ehab718
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0195-668X
107views
3downloads

Technical informations

Creation02/21/2022 3:32:00 PM
First validation02/21/2022 3:32:00 PM
Update time03/16/2023 6:49:47 AM
Status update03/16/2023 6:49:46 AM
Last indexation02/12/2024 1:40:41 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack